Today at the @ema.europa.eu Cancer Medicines Forum, EORTC CEO Denis Lacombe highlights collaborative models between industry & academia to drive treatment optimisation post-approval. Independent research partnerships are essential for real-world evidence & better patient outcomes. #CancerResearch

Every patient is important. ➡️Today we launch #NoPatientLeftBehind. From rare cancers to optimised treatments, help us drive real-world clinical research impact for those who need it most. 🔗 Support research that puts patients first: donate.eortcresearchfund.org/eoy/ #CancerCareForAll

👏 Earlier today at ISPOR Europe, our CEO Denis Lacombe moderated the plenary session “Pragmatic Trials — Bridging Research and Real-World Care”. 🔗 Read more: www.eortc.org/blog/2025/11... #ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials

🤝 We would like to thank all our contributors and supporters for the incredible support of Patient Days 2025, which took place last week. Your engagement made it a truly meaningful event for everyone involved. #PatientDays #EORTC

📢 EORTC is proud to join ISPOR Europe 2025! CEO Denis Lacombe will moderate the plenary: “Pragmatic Trials — Bridging Research and Real-World Care”. Posters by Fabio Borges, Maria Teixeira & Claire Piccinin. 🔗 www.eortc.org/blog/2025/11... #HEOR #ClinicalTrials #ISPOREurope

🤝 As we close #PatientDays 2025, we reflect on the powerful exchanges that took place. This event reaffirmed the importance of integrating patient perspectives into research and care. Thank you to all who contributed to this meaningful dialogue. #CancerResearch #ClinicalTrials

🎉 What a day at #EORTC #PatientDays! Day 1 was packed with energy, empathy and honest round table talks. Thanks to all who joined, your voices are shaping the future of cancer care. 👋 See you tomorrow! 🔗https://www.eortc.org/event/patient-days-2025/?tab=1 #CancerCare #PatientEngagement #Oncology

This November, the EORTC Cancer Research Fund is putting patients at the heart of research. From rare cancers to treatment optimisation, no patient is left behind. Learn more: eortcresearchfund.org #LeavingNoCancerPatientBehind

🤝 EORTC #PatientDays kicks off today in Brussels! Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life. 🔗 Learn more: www.eortc.org/event/patien... #CancerResearch #Oncology #ClinicalTrials

📢 New insights from PEACE-1 This post-hoc analysis examines how adjusting for abiraterone-prednisone cross-over impacts survival outcomes in de novo mCSPC. A key step in refining trial interpretation. 🔗 Read more: www.eortc.org/publications/ #PEACE1 #ProstateCancer #ClinicalTrials #EORTC

🎥 A highlight during #PinkOctober: Behind the scenes with the EORTC Breast Cancer Group. Watch the full video now 👉 youtu.be/uRqBvA9wpig For more info visit www.eortc.org/research_fie... #BreastCancerAwarenessMonth #EORTCBreast #CancerResearch #ClinicalTrials #Oncology

📢New in Lung Cancer Journal! A pan-European panel led by the #EORTClung reviews 105 clinical cases to define resectable stage III NSCLC for trial inclusion. This consensus aims to improve patient selection and trial consistency across Europe. 🔗Read here: www.eortc.org/publications/

📢 Join our team in #Brussels! The EORTC Projects and Services department is looking for a Project Manager. Do you have a master’s degree, a 5-year experience in a project management role and are you looking for a new challenge? 👉 Apply now: www.eortc.org/job/project-... #Jobs

📢 New publication alert! EORTC’s RENALUT trial explores [177Lu]Lu-PSMA-617 in metastatic ccRCC. The protocol summary is now out in European Urology Oncology, highlighting radioligand therapy’s potential. 🔗 www.eortc.org/publications/ #EORTC #RENALUT #ccRCC

👏 Today & tomorrow at #ISOQOL 2025, @eortc.org #QualityofLife Group & colleagues will present 4 posters, exploring topics like ePRO implementation, side-effect burden measurement, and creating the PRO-AE inventory. 🔍 Learn more: www.eortc.org/blog/2025/10... #GivingVoice2Patients #CancerResearch

📣 Exciting news! @eortc.org, through its #QualityofLife (QoL) Group, is supporting #ISOQOL 2025 and will share insights into its latest QoL research through a series of impactful abstracts presented at the conference. Learn more 👇 www.eortc.org/blog/2025/10... #GivingVoice2Patients #CancerResearch

🙌 That’s a wrap on #ESMO25! EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation. Thanks to all collaborators and patients who make this work possible. 🔗 Full summary: www.eortc.org/blog/2025/10... #CancerResearch #ClinicalTrials

📢 Today is #WorldStatisticsDay, a moment to reflect on the tools that shape clinical research and medical progress. Do you feel p-values satisfy the needs of clinical research in summarizing proof? 💬 Drop your thoughts in the comments, we’re reading! Know more: www.eortc.org/blog/2025/10...

👏 Congratulations to our @eortc.org #QualityofLife Group members Veronika Engele & Louis Fox for their great presentations at #ESMO25. 🏅 And well done Veronika Engele for winning the ESMO 2025 Best Poster for Psycho-oncology! 💪 #CancerResearch #GivingVoice2Patients @kingscollegelondon.bsky.social

📢 Today we highlight a critical topic at #ESMO25: Eva Blondeaux presents on discontinuation and attrition in first-line RCTs for solid tumors. What do these trends mean for trial design and patient outcomes? Don't miss it! 🕥 10:45–10:50 #CancerResearch #EORTC #Oncology

CSO was at #ESMO2025 today, hosting a symposium to discuss our work in advancing patient-centred cancer care, and how best to engage colleagues and the broader community in Europe and beyond. #CommonSenseOncology #CancerCare

👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement! Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes. 📢 Don't miss it! #Oncology #PatientEngagement #EORTC

👏 Well done to Denis Lacombe for a compelling session today at #ESMO25! Together, we’re shaping a future of cancer research that’s smarter and more inclusive. #EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social

Today at #ESMO25, EORTC CEO Denis Lacombe speaks on two key challenges in cancer research: ➡️ Are we using therapies optimally in real-world care? ➡️ Are clinical trials truly inclusive of all patients? Two sessions, one goal: research that’s both effective and equitable. #ClinicalTrials #DEI

🚨 Big news from #EANO2025! Final #CATNON results show adding 12 cycles of temozolomide after radiotherapy doubles survival in IDH-mutant anaplastic astrocytoma: 12.5 vs 6 years. 🌍 A global academic effort in rare cancers. 🔗 Full story: www.eortc.org/blog/2025/10... @eanoassociation.bsky.social

👏 Huge congrats to Madeline Pe for her fantastic presentation at #ESMO25! Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research. Proud moment for EORTC! 📸 #QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org

📢 EORTC is hiring a Secretary for the Statistics Department (Replacement contract) Organized, tech-savvy, and ready to support cancer research? Help our team with agendas, travel, meetings, presentations, and research project coordination. 📩 Apply now: www.eortc.org/job/secretar...

👏 We’re proud to see Madeline Pe, Head of EORTC #QualityofLife Department, present key insights from the SISAQOL-IMI initiative at #ESMO25. Four years of work to improve how patient-reported outcomes are analysed in cancer trials. 📢 Catch her talk today at 14:35 in Berlin! @qol.eortc.org

ESMO 2025: A leadership moment! EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action. Sharing ideas, energy, and a vision for better cancer care across Europe. Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.

📍We are in Berlin for #ESMO25. Come and visit us at our booth #S4040. Don't miss EORTC's upcoming sessions, mini-oral sessions, posters and more. Stay tuned! 👉 More info: www.eortc.org/blog/2025/10... @myesmo.bsky.social #EORTC #ClinicalTrials #CancerResearch #Oncology #TreatmentOptimisation

🚀 EORTC is at #ESMO25! As the Congress begins in Berlin, we’re proud to contribute with scientific presentations and expert insights. Looking forward to a week of collaboration, innovation & progress in cancer research. 🔗 More info: www.eortc.org/blog/2025/10... #CancerResearch #ClinicalTrials

📢 @eanoassociation.bsky.social 2025 kicks off today in Prague! Proud to see strong #EORTC representation with six abstracts and a joint session with BTG featuring EORTC-led projects on clinical trial planning. More info 👉 www.eortc.org/blog/2025/10... #EANO2025 #NeuroOncology @qol.eortc.org

🎗️ Advancing breast cancer care takes all of us. EORTC leads with cutting-edge trials, global partnerships & impactful science this #BreastCancerAwarenessMonth. 🔗 Read more: www.eortc.org/blog/2025/10... #PinkOctober #EORTCBreast #EORTCqol #CancerResearch #ClinicalTrials #Oncology #ResearchImpact

We are proud that our EORTC President @winettevandergraaf.bsky.social and esteemed colleagues will be contributing to the CSO symposium where the importance of patient-centred outcomes and global collaboration will be highlighted! Looking forward to the outcome of this important event.

Just published! Our EORTC-1219/DAHANCA-29 trial shows that prospective case reviews (p-ICR) improve radiotherapy planning in head & neck cancer. ✅ Better delineation & protocol compliance 📊 Dose planning stayed high 🔗 eortc.org/publications/ #Radiotherapy #QualityAssurance #EORTC #ClinicalTrials

📢 This #PinkOctober, EORTC highlights #EBCC15 — the 15th European Breast Cancer Conference with EUSOMA & Europa Donna. 🗓️ 25–27 March 2026, Barcelona 📝 Abstracts open until 3 November: event.eortc.org/ebcc15/call-... #EORTCBreast #CancerResearch #Oncology

🔬 On the occasion of @eanm.org, #EORTC highlights its work in nuclear medicine : ✅ LUMEN-1: Brain tumours ✅ RENALUT: Kidney cancer ✅ PEACE III: Prostate cancer Improving outcomes, expanding options. Read the full article: www.eortc.org/blog/2025/10... #RLT #CancerResearch #ClinicalTrials

🚀Exciting News! We're proud to support the launch of the World Health Organization Global Clinical Trial Forum (#GCTF) network. This vital network aims to advance the Global Action Plan for Clinical Trials Ecosystem Strengthening and promote best practices worldwide. 👉 www.who.int/news/item/07...

📢 New publication alert! #EORTC CEO Denis Lacombe leads a new publication reflecting the DE-ESCALATE prostate #cancertrial. The article calls for proportionate EU regulation to support pragmatic, patient-centred trials. 🔗Read more: www.eortc.org/publications/ #CancerResearch #ClinicalTrials

Proud to support @bigxresearch.bsky.social Pink October webinar on 22 Oct! A vital dialogue on climate change & breast cancer research. Let’s rethink trials for a healthier planet & better outcomes. 🔗All the information here: eortc.org/event/bigs-a... bigagainstbreastcancer.org/events/big-p...

📢 Today, at the NASEM National Cancer Policy Forum, our colleague Claire Piccinin will present perspectives from EORTC on patient-centred initiatives and ongoing efforts to promote the impactful use of patient-reported outcome data 👇 www.nationalacademies.org/event/44567_... #QLG @qol.eortc.org

LIVE from @europarl.europa.eu. EORTC, MEPs Metz & Jerkovic call for treatment optimisation through independent research. 📢EORTC & @cancerpatientseu.bsky.social launched a White Paper at this event urging broad support to improve Europe’s health outcomes. Read more: www.eortc.org/blog/2025/09...

On #WorldCancerResearchDay, #EORTC stands for independent clinical research that puts patients first. Too many face avoidable toxicity from high-dose cancer drugs. We’re rethinking what “effective” means: right dose, right duration, right outcome. #WCRD #CancerResearch #ClinicalResearch

The DREAM trial (first EORTC-JCOG intergroup study) is now published in JAMA Surgery! Made possible by the EORTC Fellowship, this global academic partnership shows how collaboration drives impactful cancer research. 🔗 jamanetwork.com/journals/jam... #DREAMTrial #GlobalOncology

Yesterday was World Radiotherapy Awareness Day. A day to reflect on radiotherapy’s impact. Take a look at a recent study on how tumour irradiation can trigger immunogenic responses. Radiotherapy is evolving beyond local control. 🔗 Read more: doi.org/10.1016/j.ra... #RTQA

The Boots Group & EORTC support World Radiotherapy Awareness Day. Mrs. Ornella Barra, CEO of Boots, shares why radiotherapy matters & why access must be equal. EORTC’s E²-RADIatE is Europe’s only radiation oncology platform driving innovation with real-world data. studio.youtube.com/video/CcyY-6...

🔔 New in @thelancetoncol.bsky.social: Policy review led by Ian Tannock & Madeline Pe with EORTC & CSO highlights the critical role of patient quality of life data in the evaluation of treatments for people with advanced cancer. 📖Read more: www.eortc.org/blog/2025/09... #CancerResearch #QualityofLife

📢 EORTC is hiring a full-time Events and Communications Assistant! Support international meetings & contribute to impactful communications. Are you organised, detail-oriented & passionate about events? 👉 Apply now: www.eortc.org/job/events-c... #EventsJobs #EORTC #CancerResearch

A call for equity in cancer care from HRH Princess Dina. Radiotherapy is vital for 1 in 2 cancer patients, yet access remains unequal. As EORTC-ECRF Honorary President, she supports research and innovation to change that. 🎥 Watch her message ahead of #WRAD on Sept 7: www.youtube.com/watch?v=PzKv...

📢 Virginia Delucchi presented her poster at #ISCB46 in Basel! Her study reviewed 500+ RCTs of solid tumours and found that while discontinuation is widely reported, post-treatment data often isn’t. Potentially leading to misinterpretation of treatment effects. #CancerCare #ClinicalTrials